Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Protokinetix Inc (PKTX)

Protokinetix Inc (PKTX)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K N/A
  • Shares Outstanding, K N/A
  • Annual Sales, $ 0 K
  • Annual Income, $ 0 K
  • 60-Month Beta N/A
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book N/A
Trade PKTX with:
  • Price/Earnings ttm N/A
  • Earnings Per Share ttm N/A
  • Most Recent Earnings N/A on N/A
  • Next Earnings Date N/A
  • Annual Dividend & Yield N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.0840 +19.05%
on 11/04/20
0.1105 -9.50%
on 11/30/20
unch (unch)
since 10/29/20
3-Month
0.0785 +27.39%
on 09/02/20
0.1500 -33.33%
on 09/16/20
+0.0200 (+25.00%)
since 09/01/20
52-Week
0.0510 +96.08%
on 07/10/20
0.2200 -54.55%
on 03/16/20
+0.0025 (+2.56%)
since 11/29/19

Most Recent Stories

More News
Research Paper Showing ProtoKinetix AAGP(R) Enhanced Stem Cell Derived Retina Precursor Cells Restoration of Vision

ProtoKinetix, Incorporated (www.protokinetix.com) (the "Company" or "ProtoKinetix") (OTCQB: PKTX), a clinical-stage biomedical company, today announced the submission of a research paper describing and...

PKTX : 0.1000 (+10.50%)
ProtoKinetix AAGP(R) Restores Vision in Blind Test Subjects

ProtoKinetix, Incorporated (www.protokinetix.com) (the "Company" or "ProtoKinetix") (OTCQB: PKTX), a clinical-stage biomedical company, today announced that after the conclusion of 4-years of extensive...

PKTX : 0.1000 (+10.50%)
Ammendments to ProtoKinetix AAGP(R) Protocol for Continuation of Phase 1 Human Trials Have Been Approved by Health Canada

ProtoKinetix, Incorporated (www.protokinetix.com) (the "Company" or "ProtoKinetix") (OTCQB: PKTX), a clinical-stage biomedical company, today announced that Dr. James Shapiro has received approval from...

PKTX : 0.1000 (+10.50%)
ProtoKinetix AAGP(R) Moves to Whole Organ Transplantation Testing

ProtoKinetix, Incorporated (www.protokinetix.com) (the "Company" or "ProtoKinetix") (OTCQB: PKTX), a clinical-stage biomedical company, today announced that due to the results that AAGP(R) has achieved...

PKTX : 0.1000 (+10.50%)
ProtoKinetix AAGP(R) Exhibits Efficacy and Safety in Model of Dry Eye Disease

ProtoKinetix, Incorporated (www.protokinetix.com) (the "Company" or "ProtoKinetix") (OTCQB:PKTX), a clinical-stage biomedical company, having recently announced filing for patent protection for new applications...

PKTX : 0.1000 (+10.50%)
ProtoKinetix Ready to Ship AAGP(R) to the University of Alberta for the Continuation of Phase 1 Human Trials

ProtoKinetix, Incorporated (www.protokinetix.com) (the "Company" or "ProtoKinetix") (OTCQB: PKTX), a clinical-stage biomedical company, today announced an update to the Press Release of January 24, 2020....

PKTX : 0.1000 (+10.50%)
ProtoKinetix Files for Patent Protection for AAGP(R) to be Used in Dry Eye Disease

ProtoKinetix, Incorporated (www.protokinetix.com) (the "Company" or "ProtoKinetix") (OTCQB:PKTX) recently filed for patent protection for new applications of its AAGP(R) molecule.

PKTX : 0.1000 (+10.50%)
ProtoKinetix Announces Progress in the use of AAGP(R) in Cardiovascular Medicine

ProtoKinetix, Incorporated (www.protokinetix.com) (the "Company" or "ProtoKinetix") (OTCQB: PKTX) announces the progress of screening PKX-001 for cardiometabolic disorders.

PKTX : 0.1000 (+10.50%)
ProtoKinetix Files for Patent Protection for the Use of AAGP(R) in Transplant Medicine

ProtoKinetix, Incorporated (www.protokinetix.com) (the "Company" or "ProtoKinetix") (OTCQB:PKTX) recently filed for patent protection for a new application of its AAGP(R) molecule.

PKTX : 0.1000 (+10.50%)
ProtoKinetix Takes Delivery of GMP AAGP(R) PKX-001 Dedicated for Phase 1 Trial

ProtoKinetix, Incorporated (www.protokinetix.com) (the "Company" or "ProtoKinetix") (OTCQB:PKTX) announces that the Company has taken procession of an additional 200 grams of GMP grade PKX-001 (AAGP(R))...

PKTX : 0.1000 (+10.50%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 56% Sell with a Weakest short term outlook on maintaining the current direction.

See More Share

Key Turning Points

2nd Resistance Point 0.1087
1st Resistance Point 0.1044
Last Price 0.1000
1st Support Level 0.0931
2nd Support Level 0.0861

See More

52-Week High 0.2200
Fibonacci 61.8% 0.1554
Fibonacci 50% 0.1355
Fibonacci 38.2% 0.1156
Last Price 0.1000
52-Week Low 0.0510

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar